Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Net Margin (2016 - 2020)

Syndax Pharmaceuticals (SNDX) has disclosed Net Margin for 6 consecutive years, with 5226.32% as the latest value for Q4 2020.

  • For Q4 2020, Net Margin fell 148816.0% year-over-year to 5226.32%; the TTM value through Sep 2021 reached 5226.32%, down 89092.0%, while the annual FY2025 figure was 165.6%, 118050.0% up from the prior year.
  • Net Margin hit 5226.32% in Q4 2020 for Syndax Pharmaceuticals, roughly flat from 5238.26% in the prior quarter.
  • Across five years, Net Margin topped out at 1594.89% in Q4 2017 and bottomed at 5238.26% in Q3 2020.
  • Average Net Margin over 5 years is 4162.45%, with a median of 4309.0% recorded in 2017.
  • Year-over-year, Net Margin soared 3175379bps in 2016 and then plummeted -349274bps in 2018.
  • Syndax Pharmaceuticals' Net Margin stood at 3564.92% in 2016, then skyrocketed by 55bps to 1594.89% in 2017, then plummeted by -219bps to 5087.63% in 2018, then increased by 27bps to 3738.16% in 2019, then crashed by -40bps to 5226.32% in 2020.
  • According to Business Quant data, Net Margin over the past three periods came in at 5226.32%, 5238.26%, and 4382.59% for Q4 2020, Q3 2020, and Q2 2020 respectively.